The decreased expression of antiapoptoticBcl-xL in OUMS-27 treated by 15d-PGJ2 led us to examine the expression in thetissue of human chondrosarcoma samples to study the clinical application ofdifferentiation therapy by PPARγ activation. Here, PPARG is linked to chondrosarcoma.